Jacoline van Laar - Concepedia

Author

Jacoline van Laar

Also Known As

J van Laar, J. van Laar, Jacoline van Laar

Publications

333

Citations

H-Index

Concepts

All Affiliations

Jacoline van Laar is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, natural sciences, and molecular biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	226
2	Natural Sciences	2	2	117
3	Cell Biology	2	2	77
4	Health Sciences	1	1	61
5	Biochemistry	1	1	61

Jacoline van Laar

Publications

326

Citations

H-Index

Page 1

	Year	Citations
Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia Jacqueline M. Tromp, Christian R. Geest, Esther C.W. Breij, Clinical Cancer Research	2011	90
The impact of SF3B1 mutations in CLL on the DNA-damage response G. Doreen te Raa, I. A. M. Derks, Veronika Navrkalová, Leukemia ChromatinGenome InstabilitySomatic VariantMedicineGenetics	2014	88
Altered Linkage of Hydroxyacyl Chains in Lipid A of Campylobacter jejuni Reduces TLR4 Activation and Antimicrobial Resistance Andries van Mourik, Liana Steeghs, Jacoline van Laar, Journal of Biological Chemistry GlycobiologyPolysaccharideAntibiotic ResistanceLipid ADrug Resistance	2010	61
ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia Sanne H. Tonino, Jacoline van Laar, M. H. van Oers, Oncogene Hematological MalignancyTumor BiologyMedicineImmunologyNoxa Overcomes Chemoresistance	2010	48
CLL cells are resistant to smac mimetics because of an inability to form a ripoptosome complex Chiel Maas, J M Tromp, Jacoline van Laar, Cell Death and Disease ApoptosisImmunologyMolecular BiologyCell DeathCytoskeleton	2013	29
SF3B1 Mutations in CLL Are Equivalent to p53/ATM Dysfunction and Cause Defective Puma Upregulation in Response to Chemotherapy Doreen te Raa, Ingrid A. M. Derks, Dieuwertje M. Luijks, Blood	2012	10

Page 1